C-reactive protein: adjunct to cardiovascular risk assessment.

@article{Bahadursingh2009CreactivePA,
  title={C-reactive protein: adjunct to cardiovascular risk assessment.},
  author={Sarasvati Bahadursingh and Kae Beharry and Kasthurba Maharaj and Candace Mootoo and Priyanka Sharma and Jagir Singh and Keith Teelucksingh and R. Tilluckdharry},
  journal={The West Indian medical journal},
  year={2009},
  volume={58 6},
  pages={
          551-5
        }
}
OBJECTIVES The study aimed to investigate whether elevated plasma high sensitivity C-reactive protein (hs-CRP) levels are independently associated with an increased risk of cardiovascular disease (CVD) and to then assess the effectiveness of the addition of hs-CRP testing to cardiovascular risk assessment by standard lipid screening. METHODS A retrospective hospital-based case-control study was designed. All patients attending Cross Crossing Medical Centre (CCMC) for routine cardiovascular… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 13 REFERENCES

Lecture cardiovascular medicine at the turn of the millennium: Triumphs, concerns and opportunities

Braunwald E. Shattuck
  • N Engl J Med
  • 1997
VIEW 3 EXCERPTS
HIGHLY INFLUENTIAL

The New Heart Alarm

J. Walker
  • Men’s Health 2003 January/February
  • 2003
VIEW 1 EXCERPT

Effect of statin therapy on C - reactive protein levels

PM Ridker, Wilson PWF, SM Grundy
  • The Pravastatin Inflammation / CRP Evaluation ( PRINCE ) : a randomized trial and cohort study JAMA
  • 2001

Effects of low-dose asprin on serum C-reactive protein and thromboxane B2 concentrations: a placebo-controlled study using a highly sensitive C-reactive protein assay

M Feldman, I Jialal, S Deveraj, B. Cryer
  • J Am Coll Cardiol
  • 2001
VIEW 1 EXCERPT